Page last updated: 2024-08-22

(1S,2R)-tranylcypromine and Experimental Neoplasms

(1S,2R)-tranylcypromine has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, M; Jiang, Q; Wang, J; Wang, X; Yan, J; Zhang, C; Zhang, X; Zhao, D; Zhao, L	1

Other Studies

1 other study(ies) available for (1S,2R)-tranylcypromine and Experimental Neoplasms

Article	Year
Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors. European journal of medicinal chemistry, 2020, May-15, Volume: 194 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Quinolines; Structure-Activity Relationship	2020

Article

Year

Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.

European journal of medicinal chemistry, 2020, May-15, Volume: 194

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Quinolines; Structure-Activity Relationship

2020